STOCK TITAN

Director sale: UVE (NYSE: UVE) files to sell 20,000 shares on 06/11/2026

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

UVE-related filing reports a proposed sale of 20,000 common shares on 06/11/2026. The filing lists the sale as Lieu Compensation to be effected for cash through Raymond James & Associates. The notice also lists three prior sales of 20,000 shares each on 03/25/2026, 04/29/2026, and 05/15/2026 with transaction proceeds shown.

Positive

  • None.

Negative

  • None.

Insights

Form 144 notifies a planned insider sale of 20,000 shares on 06/11/2026.

The notice identifies the sales method as cash disposition and the stated reason as Lieu Compensation. The excerpt lists broker details (Raymond James & Associates) and an aggregate transaction value for the 20,000 shares.

Past sales of 20,000 shares on 03/25/2026, 04/29/2026, and 05/15/2026 are shown with their proceeds; timing and routing imply routine planned dispositions. Cash‑flow treatment: proceeds payable to the selling holder as disclosed in the excerpt.

Proposed sale 20,000 shares proposed sale on 06/11/2026
Proceeds (listed) $757,000.00 aggregate value shown for 20,000 shares on 06/11/2026
Prior sale 1 20,000 shares sold 03/25/2026 for $691,066.05
Prior sale 2 proceeds $792,743.69 proceeds for 20,000 shares sold 04/29/2026
Prior sale 3 proceeds $773,576.09 proceeds for 20,000 shares sold 05/15/2026
Listed broker Raymond James & Associates broker shown for proposed transaction
Form 144 regulatory
"144: Securities To Be Sold"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Lieu Compensation financial
"Common | 06/11/2026 | Lieu Compensation"
Issuer regulatory
"Lieu Compensation | Issuer | 20000"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the UVE Form 144 report?

The filing reports a proposed sale of 20,000 common shares on 06/11/2026 described as Lieu Compensation. It lists Raymond James & Associates as the broker and shows prior sales of 20,000 shares on three earlier dates with proceeds.

Who is the broker and how is the sale described in the UVE filing?

The broker is listed as Raymond James & Associates. The transaction is described as Lieu Compensation and designated as an issuer sale for cash on 06/11/2026 in the excerpt provided.

What prior insider sales does the Form 144 show for UVE?

The excerpt shows prior sales by the same reporting address of 20,000 shares on 03/25/2026, 04/29/2026, and 05/15/2026, with proceeds of $691,066.05, $792,743.69, and $773,576.09 respectively.

Will the company receive proceeds from this transaction?

The excerpt labels the transaction method as Cash and lists the sale as Issuer in the securities-to-be-sold row; the filing indicates cash proceeds are associated with the sale on 06/11/2026 as shown in the table.